SARS-CoV-2 Omicron Infections among Vaccinated Maintenance Hemodialysis Patients: Outcomes and Comparison to Delta Variant
Nephron · 2024
DOI: 10.1159/000536521 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Nephron, 2024. Verfasst von Ori Wand und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary Medicine, Barzilai University Medical Center, Ashkelon, Israel. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Renal Dialysis, COVID-19 Vaccines. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Infections with B.1.1.529 (Omicron) variants of SARS-CoV-2 became predominant worldwide since late 2021, replacing the previously dominant B.1.617.2 variant (Delta). While those variants are highly transmissible and can evade vaccine protection, population studies suggested that outcomes from infection with Omicron variants are better compared with Delta. Data regarding prognosis of maintenance hemodialysis (MHD) patients infected with Omicron versus Delta variants, however, are scarce.
Methods
This retrospective cohort study includes all patients with end-stage kidney disease treated with MHD in Meir Medical Center, Kfar-Saba, Israel, that were diagnosed with SARS-CoV-2 infection between June 2021 and May 2022.
Results
Twenty-six subjects were diagnosed with the Delta variant and 71 with Omicron. Despite comparable age between groups and higher mean vaccine doses prior to the infection among the Omicron group (p < 0.001), SARS-CoV-2 infection severity was significantly worse among MHD infected with the Delta variant: 50% developed severe or critical COVID-19 versus 5% in the Omicron group (p < 0.001). Over half of MHD infected with Omicron (57%) were asymptomatic during their illness. The 30-day mortality rate for the whole cohort was 5.2%. It was significantly higher among MHD in the Delta group than in the Omicron group (5/26, 19.2% vs. 0/71, p < 0.001), as was the 90-day mortality rate (5/26, 19.2% vs. 3/71, 4.2%, p = 0.02).
Conclusions
Infection with the SARS-CoV-2 Delta variant was associated with worse outcomes compared with Omicron, among subjects on MHD. However, despite mild disease among vaccinated MHD patients, infection with Omicron variant was still associated with the significant 90-day mortality rate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary Medicine, Barzilai University Medical Center, Ashkelon, Israel.
- Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
- Department of Anesthesia, Meir Medical Center, Kfar Saba, Israel.
- Department of Nephrology and Hypertension, Meir Medical Center, Kfar Saba, Israel.
- Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Zitieren
APA
Wand, O., Drori, I., Einbinder, Y., Nacasch, N., Benchetrit, S., Breslavsky, A., & Cohen-Hagai, K. (2024). SARS-CoV-2 Omicron Infections among Vaccinated Maintenance Hemodialysis Patients: Outcomes and Comparison to Delta Variant. Nephron. https://doi.org/10.1159/000536521
Vancouver
Wand O, Drori I, Einbinder Y, Nacasch N, Benchetrit S, Breslavsky A, et al. SARS-CoV-2 Omicron Infections among Vaccinated Maintenance Hemodialysis Patients: Outcomes and Comparison to Delta Variant. Nephron. 2024. doi:10.1159/000536521
BibTeX
@article{Wand2024,
author = {Wand, Ori and Drori, Idan and Einbinder, Yael and Nacasch, Naomi and Benchetrit, Sydney and Breslavsky, Anna and Cohen-Hagai, Keren},
title = {SARS-CoV-2 Omicron Infections among Vaccinated Maintenance Hemodialysis Patients: Outcomes and Comparison to Delta Variant},
journal = {Nephron},
year = {2024},
doi = {10.1159/000536521}
}
EUVIMED